Application 215700

Type
NDA
Sponsor
INFORLIFE SA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDENOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDEINJECTABLE;INJECTION4MG(16MCG PER ML)0.9%NoNo
002NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDENOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDEINJECTABLE;INJECTION8MG(32MCG PER ML)0.9%NoNo
003NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDENOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDEINJECTABLE;INJECTION16MG(64MCG PER ML)0.9%NoNo
004NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDENOREPINEPHRINE BITARTRATESOLUTION;INTRAVENOUSEQ 32MG BASE/250ML (EQ 128MCG BASE/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
44567-640NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-640NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-640NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-641NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-641NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-641NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-642NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-642NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent
44567-642NOREPINEPHRINE BITARTRATENOREPINEPHRINE BITARTRATEWG Critical Care, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74925SUPPL 2023-07-31
74917SUPPL 2023-07-28
74266ORIG 2023-05-16
73399SUPPL 2023-02-07
73398SUPPL 2023-02-07
72091ORIG2022-09-16
72090ORIG2022-09-16